| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |